SCHEMBL4030433

SCHEMBL4030433

CS(=O)(=O)c1ccc(CNC(=O)C2CCNCC2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
OGA O60502 1/20 0.51
HTR2C P28335 1/20 0.50
TP53 P04637 1/20 0.49
SLC13A5 Q86YT5 1/20 0.48
USP2 O75604 1/20 0.48
HPGD P15428 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
EPHX2 P34913 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
ERCC1 P07992 1/20 0.47
ERCC4 Q92889 1/20 0.47
MAPT P10636 1/20 0.47
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL933462 0.87 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2OGATP53USP2
SCHEMBL13745651 0.83 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2HTR2CTP53USP2
SCHEMBL13746002 0.83 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2HTR2CTP53USP2
SCHEMBL4037264 0.80 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CTP53SLC13A5
SCHEMBL172079 0.80 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CSLC13A5USP2
SCHEMBL526330 0.80 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2HTR2CUSP2HPGD
SCHEMBL13745650 0.80 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTR2CTP53EPHX2
SCHEMBL13746423 0.80 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HTR2CTP53USP2
Hydrochloric Acid SCHEMBL30164247 0.79 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HTR2CSLC13A5USP2
Hydrochloric Acid SCHEMBL6479155 0.79 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2HTR2CTP53SLC13A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed